Latest Insider Transactions at Abeona Therapeutics Inc. (ABEO)
This section provides a real-time view of insider transactions for Abeona Therapeutics Inc. (ABEO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ABEONA THERAPEUTICS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ABEONA THERAPEUTICS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2021
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
1,345
-0.48%
|
$2,690
$2.43 P/Share
|
Feb 18
2021
|
Todd Wider Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,345
+0.48%
|
$1,345
$1.28 P/Share
|
Feb 17
2021
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
320,000
-53.64%
|
$640,000
$2.34 P/Share
|
Feb 17
2021
|
Todd Wider Director |
BUY
Exercise of conversion of derivative security
|
Direct |
320,000
+8.75%
|
$320,000
$1.28 P/Share
|
Feb 17
2021
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
132,664
-100.0%
|
$265,328
$2.34 P/Share
|
Feb 16
2021
|
Sco Capital Partners LLC Director |
SELL
Open market or private sale
|
Indirect |
120,000
-1.06%
|
$240,000
$2.97 P/Share
|
Feb 08
2021
|
Sco Capital Partners LLC Director |
SELL
Open market or private sale
|
Indirect |
240,000
-2.07%
|
$720,000
$3.01 P/Share
|
Jan 19
2021
|
Sco Capital Partners LLC Director |
SELL
Open market or private sale
|
Indirect |
207,117
-1.75%
|
$414,234
$2.08 P/Share
|
Jan 15
2021
|
Sco Capital Partners LLC Director |
SELL
Open market or private sale
|
Indirect |
81,283
-0.68%
|
$162,566
$2.02 P/Share
|
Jan 14
2021
|
Sco Capital Partners LLC Director |
SELL
Open market or private sale
|
Indirect |
31,600
-0.27%
|
$63,200
$2.0 P/Share
|
Jan 04
2021
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
30,488
-18.69%
|
$30,488
$1.54 P/Share
|
Jan 04
2021
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
33,876
-10.91%
|
$33,876
$1.54 P/Share
|
Dec 31
2020
|
Paul Elliot Mann Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
609,755
-78.89%
|
-
|
Dec 31
2020
|
Todd Wider Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
609,755
-66.26%
|
-
|
Dec 18
2020
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
17,079
-2.16%
|
$17,079
$1.59 P/Share
|
Dec 02
2020
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
30,488
-3.72%
|
$30,488
$1.49 P/Share
|
Dec 02
2020
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
33,876
-3.55%
|
$33,876
$1.49 P/Share
|
Nov 23
2020
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
17,969
-1.85%
|
$17,969
$1.33 P/Share
|
Nov 02
2020
|
Paul Elliot Mann Director |
SELL
Open market or private sale
|
Direct |
30,488
-3.58%
|
$30,488
$1.04 P/Share
|
Nov 02
2020
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
33,876
-3.37%
|
$33,876
$1.04 P/Share
|
Oct 09
2020
|
Edward Carr Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
143,182
+42.12%
|
-
|
Oct 08
2020
|
Todd Wider Director |
BUY
Grant, award, or other acquisition
|
Direct |
813,008
+44.7%
|
-
|
Oct 08
2020
|
Paul Elliot Mann Director |
BUY
Grant, award, or other acquisition
|
Direct |
813,008
+48.86%
|
-
|